Guido Antonellli

Nirmatrelvir and COVID-19: development, pharmacokinetics, clinical efficacy, resistance, relapse, and pharmacoeconomics

A. Casadevall, G. Antonelli, S. Shoham, 2023, International Journal of Antimicrobial Agents.